- Herpes zoster in Germany: quantifying the burden of diseaseBernhard Ultsch
Immunization Unit, Robert Koch Institute, 13086 Berlin, Germany
BMC Infect Dis 11:173. 2011..To support the decision making process related to a potential vaccination recommendation, we estimated annual HZ disease burden in people aged≥50 years in Germany by utilizing various data sources...
- Epidemiology and cost of herpes zoster and postherpetic neuralgia in GermanyBernhard Ultsch
Immunisation Unit, Department for Infectious Disease Epidemiology, Robert Koch Institute, DGZ Ring 1, 13086, Berlin, Germany
Eur J Health Econ 14:1015-26. 2013..HZ and PHN place a considerable burden on the German SHI-system. Since HZ-vaccines will soon be available, a health-economic evaluation of these vaccines should be conducted...
- Health economic evaluation of vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia in GermanyBernhard Ultsch
Immunisation Unit, Robert Koch Institute, Berlin, Germany
BMC Health Serv Res 13:359. 2013..To support an informed decision-making for a potential vaccination recommendation, we conducted a health economic evaluation to identify the most cost-effective vaccination strategy...